期刊文献+

多西他赛共聚物纳米胶束的制备及性能研究 被引量:7

Preparation and characterization of docetaxel-loaded block copolymer micelles
原文传递
导出
摘要 目的制备一种包载多西他赛的聚乳酸羟基乙酸-聚乙二醇-聚乳酸羟基乙酸(PLGA-PEG-PLGA)三嵌段共聚物纳米胶束,并考察其相关性能。方法采用开环聚合法合成共聚物,直接溶解法制备载多西他赛共聚物纳米胶束,荧光光谱法测定临界胶束浓度,高效液相色谱检测载药胶束的包封率与载药率,透析法测定载药胶束体外释放情况,扫描电镜观察纳米胶束的形态,激光粒径仪测量共聚物纳米胶束粒径及分布,改良寇氏法测定载药胶束的半数致死量。结果直接溶解法制备的共聚物纳米胶束的临界胶束浓度为4.5×10-3 g/L,多西他赛与共聚物投料比为1∶20制备的载多西他赛共聚物纳米胶束的包封率为98.20%,载药率达4.68%,在体外平稳释放时间约3 d。扫描电子显微镜观察载多西他赛共聚物纳米胶束呈类圆形,分散良好,平均粒径为30.8 nm,多元分散系数0.42。载多西他赛共聚物纳米胶束静脉注射小鼠的半数致死量为273.5 mg/kg。结论采用直接溶解法可制备一种载多西他赛的PLGA-PEG-PLGA三嵌段共聚物纳米胶束,包封率高,体外释药平稳,毒副作用小,具有潜在的临床应用价值。 Objective To investigate the preparation and characterization of docetaxel-loaded block copolymer micelles.Methods The tri-block copolymer poly(lactic-co-glycolic acid)-poly(ethylene glycol)-poly(lactic-co-glycolic acid)(PLGA-PEG-PLGA) was synthesized by ring-opening polymerization process,and the docetaxel-loaded micelles were prepared using direct dissolution method.The critical micelle concentration was measured by pyrenemonomer fluorescence probe technology;the encapsulation efficiency,loading rate,and in vitro release were determined by high-performance liquid chromatography(HPLC).The morphology and size of micelles were observed with scanning electron microscope and laser light particle size detector,respectively.The 50 % lethal dose of docetaxel-loaded micelles in mice was calculated by modified Kaber method.Results The critical micelle concentration was 4.5 × 10-3 g/L.The prepared docetaxel-loaded micelles had a spherical geometry with a median size of 30.8 nm,and the micelles possessed an eligible loading rate and encapsulation efficiency of 4.68 % and 98.20 % respectively as detected by HPLC.The in vitro release profile of docetaxel from micelles showed the continuous drug release of 3 days.The 50 % lethal dose of docetaxel-loaded micelle in mice was increased to 273.5 mg/kg,which was about 6 times higher than that of docetaxel.Conclusion It is demonstrated that the prepared docetaxel-loaded block copolymer micelles possess high drug encapsulation efficiency,stable in vitro drug release and low systemic toxicity,which has potential clinical value.
出处 《生物医学工程与临床》 CAS 2011年第2期99-102,共4页 Biomedical Engineering and Clinical Medicine
基金 福建省自然科学基金(2009J05066)
关键词 多西他赛 聚合物 胶束 缓释材料 纳米粒子 聚乳酸羟基乙酸 聚乙二醇 docetaxel copolymer micelle sustained-release material nanoparticles poly(lactic-co-glycolic acid) poly(ethylene glycol)
  • 相关文献

参考文献10

  • 1Morse DL, Gray H, Payne CM, et ol. Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells [J]. Mol Cancer Ther, 2005, 4(10): 1495-1504.
  • 2Montero A, Fossella F, Hortobagyi G, et al. Docetaxel for treat- ment of solid tumours: a systematic review of clinical data[J]. La- ncet Oncol, 2005, 6(4): 229-239.
  • 3Gradishar WJ, Tjulandin S, Davidson N, et al. Phase Ⅲ trial ofn- anoparticle albumin-bound paclitaxel compared with polyethy- lated castor oil-based paclitaxel in women with breast cancer[J]. J Clin Oncol, 2005, 23(31): 7794-7803.
  • 4Langer CJ. CT-2103: emerging utility and therapy for solid turn- ours[J]. Expert Opin Investig Drugs, 2004, 13(11): 1501-1508.
  • 5Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres composed of methoxy poly (ethylene glycol) and poly (epsilon-caprolactone) as novel anticancer drug carriers[J]. Biomaterials, 2001, 22(13): 1697-1704.
  • 6Alien C, Maysinger D, Eisenberg A. Nano-engineering block co- polymer aggregates for drug delivery[J]. Colloids and Surfaces B: Biointerfaces, 1999, 16(1-4): 3-27.
  • 7Chen ZK, Lin LW, Yang YH, et aL US-guided interstitial chem- otherapy using paclitaxel temperature-responsive gel for breast cancer treatment in rat[J]. J Cancer Res Clin Oncol, 2010, 136 (4): 537-545.
  • 8Hans M, Shimoni K, Danino D, et al. Synthesis and character- ization of mPEG-PLA prodrug micelles[J]. Biomacromolecules, 2005, 6(5): 2708-2717.
  • 9Qiao M, Chen D, Hao T, et al. Injectable thermosensitive PLGA- PEG-PLGA triblock copolymers-based hydrogels as carriers for interleukin-2[J]. Pharmazie, 2008, 63(1): 27-30.
  • 10Ghahremankhani AA, Dorkoosh F, Dinarvand R. PLGA-PEG- PLGA tri-block copolymers as in situ gel-forming peptide delivery system: effect of formulation properties on peptide release[J]. Pharm Dev Technol, 2008, 13(1): 49-55.

同被引文献84

  • 1刘亮,晋平,张国亮,张凤宝.用于药物载体的纳米粒子的研究进展[J].现代化工,2005,25(z1):106-110. 被引量:6
  • 2李巧霞,宋宝珍,仰振球,樊红雷.香草醛交联的壳聚糖微囊的制备及表征[J].过程工程学报,2006,6(4):608-613. 被引量:11
  • 3李欣,刘燕,康艳敏,梅兴国.高效液相色谱法测定多西紫杉醇静脉纳米乳剂的含量[J].解放军药学学报,2007,23(1):32-34. 被引量:6
  • 4Danhier F, Lecouturier N, Vroman B, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation[J]. J Control Release, 2009, 133(1): 11-17.
  • 5Jain AK, Das M, Swarnakar NK, et al. Engineered PLGA nanop- articles: an emerging delivery tool in cancer therapeutics[J]. Crit Rev Ther Drug Carrier Sys4 2011, 28(1): 1-45.
  • 6Lu JM, Wang X, Matin-Muller C, et al. Current advances in res- earch and clinical applications of PLGA-based nanotechnology [J]. Expert Rev Mol Diagn, 2009, 9(4): 325-341.
  • 7Wang Y, Saad M, Pakunlu RI, et al. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-indu- cible factor 1 alpha enhances the efficacy of chemotherapy in d- rug-resistant tumor[J]. Clin Cancer Res, 2008, 14 (11): 3607- 3616.
  • 8Li Ming, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the act for process engineering approaches [J]. Inl J Pharm, 2008, 363(1-2): 26-39.
  • 9Eley JG, Mathew P. Preparation and release characteristics of i- nsulin and insulin-like growth factor-one from polymer nanop- articles[J]. J Microencapsul, 2007, 24(3): 225-234.
  • 10张阳德.纳米药物学[M].北京.化学工业出版社.2005.10

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部